BIOTECHNOLOGY VALUE FUND L P

Holdings History for TScan Therapeutics, Inc. - Voting Common Stock, par value $0.0001 per share (TCRX)

Symbol: TCRX on Nasdaq
Investment type: Equity / Voting Common Stock, par value $0.0001 per share
Latest Disclosed Shares Owned: 5,263,541 shares
Security Ownership %: 10%

BVF PARTNERS L P/IL ownership in TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX)

15 May 2025 - BVF PARTNERS L P/IL has filed an SCHEDULE 13G/A form with the Securities and Exchange Commission (SEC) disclosing ownership of 5,263,541 shares of TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX). This represents 10% ownership of the company. This is the first filing by BIOTECHNOLOGY VALUE FUND L P disclosing ownership of TScan Therapeutics, Inc. Voting Common Stock, par value $0.0001 per share (TCRX).

Reporting Name	Ownership %	Change	Value $	Shares owned	Change	Activity %	Price	Form	Report date	Filing time
BVF PARTNERS L P/IL	10%		$8,421,666	5,263,541			$1.60	13G/A	31 Mar 2025	15 May 2025, 16:40